What's New

January 2017

Change in DEA Registration Application Renewal Notification Reminder, Effective January 2017

Mylan Technologies, Inc. (January 23, 2017)

Noramco, Inc. (January 19, 2017)

Correction: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB-, 5F-AMB, 5F-APINACA, ADB-FUBINACA, NDMB-CHMICA and MDMB-FUBINACA) Into Schedule I (January 9, 2017)

Notice of Intent: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) Into Schedule I (January 9, 2017)

December 2016

Final Rule: Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines, Including Changes To Implement the International Trade Data System (ITDS); Revision of Reporting Requirements for Domestic Transactions in Listed Chemicals and Tableting and Encapsulating Machines; and Technical Amendments (PDF) (December 30, 2016)

Janssen Pharmaceutical, Inc. (December 29, 2016)

AMRI Rensselaer, Inc. (December 28, 2016)

Navinta LLC (December 28, 2016)

Bulk Manufacturer of Controlled Substances Registration (December 28, 2016)

Synthcon, LLC (December 28, 2016)

Wildlife Laboratories, Inc. (December 28, 2016)

Cayman Chemical Company (December 28, 2016)

Johnson Matthey Inc. (December 28, 2016)

Noramco, Inc. (December 28, 2016)

Importer of Controlled Substances Registration (December 28, 2016)

Notice of Intent: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB-CHMICA and MDMB-FUBINACA) Into Schedule I (December 21, 2016)

Research Triangle Institute (December 19, 2016)

Final Rule: Establishment of a New Drug Code for Marihuana Extract (December 14, 2016)

Proposed Rule: Designation of Alpha-Phenylacetoacetonitrile (APAAN), a Precursor Chemical Used in the Illicit Manufacture of Phenylacetone, Methamphetamine, and Amphetamine, as a List I Chemical (December 12, 2016)

November

Final Order: Temporary Placement of Furanyl Fentanyl Into Schedule I (November 29, 2016)

Final Order: Temporary Placement of U-47700 Into Schedule I (November 14, 2016)

Thomas Horiagon, M.D.; Decision and Order (November 10, 2016)

Waleed Khan, M.D.; Decision and Order (November 10, 2016)

Jones Total Health Care Pharmacy, L.L.C., and SND Health Care, L.L.C.; Decision and Order (November 10, 2016)

30-Day Notice (Extension): National Drug Threat Survey (November 4, 2016)

30-Day Notice (Extension): Application for Permit To Import Controlled Substances for Domestic and/or Scientific Purposes (November 3, 2016)

October

Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2016 (October 25, 2016)

Edge Pharmacy; Decision and Order (October 19, 2016)

Anderson Brecon, Inc. (October 18, 2016)

Johnson Matthey Inc. (October 18, 2016)

Johnson Matthey Inc. (October 18, 2016)

Withdrawal of Notice of Intent to Temporarily Place Mitragynine and 7-Hydroxymitragynine Into Schedule I (October 13, 2016)

Change in DEA Registration Application Renewal Notification Reminder, Effective January 1, 2017

60-Day Notice; Correction: Leadership Engagement Survey (October 6, 2016)

Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2017 (October 5, 2016)

Fisher Clinical Services, Inc. (October 4, 2016)

September

60-Day Notice: Leadership Engagement Survey (September 30, 2016)

Notice of Intent: Temporary Placement of Furanyl Fentanyl Into Schedule I (September 27, 2016)

Final Rule: Placement of Three Synthetic Phenethylamines Into Schedule I (September 27, 2016)

Cerilliant Corporation (September 26, 2016)

Catalent CTS, LLC (September 26, 2016)

Charles Szyman, D.O.; Decision and Order (September 21, 2016)

Richard J. Settles, D.O.; Decision and Order (September 21, 2016)

Kevin L. Lowe, M.D.; Decision and Order (September 21, 2016)

Nanosyn, Inc. (September 21, 2016)

R & D Systems, Inc. (September 20, 2016)

Patheon API Manufacturing, Inc. (September 20, 2016)

Euticals Inc. (September 20, 2016)

Proposed Rule: Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines (PDF) (September 15, 2016)

60-Day Notice (Extension): National Clandestine Laboratory Seizure Report (September 14, 2016)

United States Pharmacopeial Convention (September 14, 2016)

Cambrex Charles City (September 14, 2016)

Sigma-Aldrich International GMBH-Sigma Aldrich Company LLC (September 14, 2016)

Importer of Controlled Substances Registration (September 14, 2016)

Alcami Wisconsin Corporation (September 14, 2016)

Halo Pharmaceutical, Inc. (September 14, 2016)

Insys Manufacturing LLC (September 14, 2016)

AMPAC Fine Chemicals LLC (September 14, 2016)

Bulk Manufacturer of Controlled Substances Registration (September 14, 2016)

Chattem Chemicals, Inc. (September 8, 2016)

Notice of Intent: Temporary Placement of U-47700 Into Schedule I (September 7, 2016)

Final Rule: Placement of PB-22, 5F-PB-22, AB-FUBINACA and ADB-PINACA into Schedule I (September 6, 2016)

Fisher Clinical Services, Inc. (September 6, 2016)

Unither Manufacturing, LLC (September 6, 2016)

Cody Laboratories, Inc. (September 6, 2016)

Isosciences (September 6, 2016)

AMRI Rensselaer, Inc. (September 6, 2016)

30-Day Notice (Extension): U.S. Official Order Forms for Schedules I and II Controlled Substances DEA Form 222 (September 6, 2016)